Last reviewed · How we verify
Urocortin 2, Urocortin 3
At a glance
| Generic name | Urocortin 2, Urocortin 3 |
|---|---|
| Also known as | Forearm vascular study - Forearm blood flow will be measured using venous occlusion plethysmography at baseline and with each dose of Ucn 2, 3 and Substance P. |
| Sponsor | University of Edinburgh |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2) (NA)
- Effect of Urocortins in Patients With Heart Failure (NA)
- Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3) (NA)
- Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers - Protocol 4 (NA)
- Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Urocortin 2, Urocortin 3 CI brief — competitive landscape report
- Urocortin 2, Urocortin 3 updates RSS · CI watch RSS
- University of Edinburgh portfolio CI